Molecular targeting agents associated with transarterial chemoembolization or radiofrequency ablation in hepatocarcinoma treatment

Figure 2 Computed tomography scan. A: An intermediate hepatocellular cancer (HCC) is showed at liver segment VII before transarterial chemoembolization (TACE). Note the HCC hyperdensity in arterial phase; B: The same tumor showed in A was observed 1 mo after TACE. Note the lipiodol impregnation of the tumor in computed tomography scan without intravenous contrast; C: An early hepatocellular cancer is showed at liver segment V before radiofrequency ablation (RFA). Note the HCC hyperdensity in arterial phase; D: The same tumor showed in C was observed 1 mo after RFA. Note the cavitation of the tumor as an image with no density.